Decoding mitochondrial stress genes in DCM: towards precision diagnosis and therapy

Bingbing Zhu1, Hai Cheng1, Jiawei Li1

  • 1Department of Cardiology, Suzhou Kowloon Hospital, Shanghai Jiaotong University School of Medicine, Suzhou, Jiangsu Province, 215028, China.

Hereditas
|April 11, 2025
PubMed
Abstract

Insights

Researchers identified five key genes (VCL, ABCB1, JAK2, KDR, NGF) linked to mitochondrial oxidative stress in dilated cardiomyopathy (DCM). These genes show diagnostic potential and may lead to new therapeutic strategies for DCM.

Area of Science:

  • Cardiology
  • Genomics
  • Biomarker Discovery

Background:

  • Mitochondrial oxidative stress is a key factor in dilated cardiomyopathy (DCM) pathogenesis.
  • Robust biomarkers for assessing oxidative stress in DCM are lacking.
  • This study investigates oxidative stress mechanisms and biomarkers in DCM.

Purpose of the Study:

  • To identify novel biomarkers for mitochondrial oxidative stress in DCM.
  • To explore the diagnostic potential of identified biomarkers.
  • To uncover potential therapeutic targets for DCM.

Main Methods:

  • Transcriptomic data analysis from GEO database.
  • Identification of hub genes using consensus clustering, protein-protein interaction, and machine learning.
  • Validation of hub gene expression in DCM patient blood samples.

Main Results:

  • Five hub genes (VCL, ABCB1, JAK2, KDR, NGF) associated with mitochondrial oxidative stress were identified.
  • Differential expression of these genes was observed between non-failing and DCM groups.
  • Significant diagnostic efficacy (AUC) was demonstrated for VCL, ABCB1, JAK2, KDR, and NGF.

Conclusions:

  • VCL, ABCB1, JAK2, KDR, and NGF are key genes in mitochondrial oxidative stress relevant to DCM.
  • These genes exhibit differential expression in DCM and myocardial infarction, indicating diagnostic potential.
  • The findings pave the way for novel therapeutic strategies targeting oxidative stress in DCM.